Senior living braces for changes in 2020 as top challenges remain
By
Lois A. Bowers
Jan 02, 2020
As 2020 begins, the senior living industry is preparing for the changing needs and wants of current and future residents as workforce and occupancy issues continue to challenge operators, according to...
Appropriations bill increases dementia research funding by $350 million to $2.8 billion
By
Lois A. Bowers
Dec 23, 2019
The appropriation bill signed into law Friday contains a $350 million increase for Alzheimer’s and dementia research funding at the National Institutes of Health. The increase brings total annual NIH...
Bipartisan bill would create Office of Alzheimer’s Disease
By
Lois A. Bowers
Dec 05, 2019
An Office of Alzheimer’s Disease would be created in Florida under a bill introduced Monday in the state House of Representatives by Rep. Matt Willhite, a Democrat, and Rep. Scott Plakon, a Republican.
‘Better business model’ needed for dementia care, Senate committee hears
By
Lois A. Bowers
Nov 21, 2019
A “better business model for the diagnosis and care of persons with Alzheimer’s disease” needs to be created, Jason Karlawish, M.D., said Wednesday at a Senate Finance Committee Subcommittee on Health...
Memory care approach cuts antipsychotic med use in more than 50% of residents: study
By
Lois A. Bowers
Nov 18, 2019
A person-centered approach to memory care led to the reduced or discontinued use of off-label antipsychotic medications in more than half of the residents of 53 long-term care communities, including assisted...
More news for Thursday, Nov. 14
Nov 14, 2019
Dec. 5 is deadline to comment on Labor Department’s proposed fluctuating workweek method of computing overtime … Citing eagerness from states, CMS announces plans to issue guidance on Medicaid block...
New Alzheimer’s task force will examine assisted living
By
Lois A. Bowers
Nov 12, 2019
Assisted living will figure squarely into the work of a new Alzheimer’s Disease and Related Dementias Task Force created in the Buckeye State under S.B. 24, which Ohio Gov. Mike DeWine (R) has signed...
Allergan subsidiary settles Alzheimer’s drug lawsuit for $750 million
By
Lois A. Bowers
Oct 31, 2019
Subsidiaries of pharmaceutical company Allergan will pay $750 million to resolve a class action lawsuit from a group of direct purchasers of Alzheimer’s drug Namenda (memantine).
‘Dementia-capable’ workforce a key to changing trajectory of disease: report
By
Lois A. Bowers
Oct 30, 2019
Building a “dementia-capable” workforce across the care continuum is one of five recommendations that could change the trajectory of the disease, which could affect 13 million people and lead to an...
‘Whole concept of senior living will change’ if Alzheimer’s drug is approved
By
Lois A. Bowers
Oct 24, 2019
“The whole concept of senior living will change,” CNBC’s Jim Cramer said Tuesday, discussing the news that Biogen and Eisai plan to seek regulatory approval of their investigational treatment for...